Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Brechot

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Presse Medicale (Paris, France : 1983)|April 20, 1991
[Monitoring of small cell bronchopulmonary cancer by bronchial biopsies]B Lebeau, F M Chauveau, J M Brechot, et al.
Revue De Pneumologie Clinique|March 18, 2005
[Treatment of anemia and bone metastasis in metastatic non-small-cell lung cancer. A French survey]J-M Brechot, N Roche, C Marichy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Presse Medicale (Paris, France : 1983)|April 20, 1991
[Monitoring of small cell bronchopulmonary cancer by bronchial biopsies]B Lebeau, F M Chauveau, J M Brechot, et al.
Revue De Pneumologie Clinique|March 18, 2005
[Treatment of anemia and bone metastasis in metastatic non-small-cell lung cancer. A French survey]J-M Brechot, N Roche, C Marichy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Pageof 4